LABD ETF: What Is It? Returns, Expense Ratio, Holdings and Alternative ETFs Explained
The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an inverse leveraged product that tracks the biotech index in the opposite direction on a daily basis. Key points to check before investing include short-term bets against the sector, hedging outlooks, holding-period management, and dividend and cost characteristics.
SubscribeWhat Is the Direxion Daily S&P Biotech Bear 3X Shares ETF?
This is an inverse leveraged ETF that aims to deliver three times the opposite of the daily return of the S&P Biotechnology Select Industry Index. It uses derivatives to meet its daily target.
It suits active short-term traders who expect the biotech sector to decline in the near term or want to hedge existing positions.
It is an actively managed ETF run by Direxion.
How Does the Direxion Daily S&P Biotech Bear 3X Shares ETF Work?
| Item | Details |
|---|---|
| Benchmark Index | S&P Biotechnology Select Industry Index |
| Strategy | Inverse leveraged (three times the opposite of the daily move) |
| Rebalancing Frequency | Daily (daily reset) |
| Dividend Frequency | Irregular (where applicable) |
| Total Expense Ratio | 1.07% |
Instead of directly holding the underlying index constituents, the fund creates opposite-direction exposure through derivatives such as swaps, tracking its target multiple on a daily basis. Because exposure is reset at the close of every trading day, holding the fund for longer than a day increases path dependency through compounding effects.
- Inverse exposure focused on declines in the biotech sector
- A short-term directional trading tool built on a daily reset
Direxion Daily S&P Biotech Bear 3X Shares ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $57.7M, and the total expense ratio is 1.07% per year.
Unlike products that track the same index in the forward direction or long ETFs on the underlying index, it provides opposite-direction exposure, and its volatility is amplified by the leverage.
Direxion Daily S&P Biotech Bear 3X Shares ETF Performance and Trends
1-Year Price Performance
Dividend & Yield
52-Week Price RangeBecause it reacts in the opposite direction to the biotech sector's moves, it tends to weaken when the sector is strong and strengthen when the sector is weak, a pattern that repeats. Due to its leverage, daily price swings tend to be larger than those of the underlying index.
When biotech sentiment is shaken by sector corrections or by interest rate and regulatory issues, trading tends to rise on short-term hedging and speculative demand. As this is a product for directional trading, fund inflows and outflows fluctuate sharply with market conditions.
Direxion Daily S&P Biotech Bear 3X Shares ETF Pros and Cons
Its strength is the ability to target amplified opposite-direction gains during biotech downturns, but decay from leverage and the daily reset is a clear drawback.
💪 Key Strengths
⚠️ Points to Watch
Direxion Daily S&P Biotech Bear 3X Shares ETF Alternative ETFs and Related Products
The forward leveraged counterpart, which tracks the same index at three times, is LABU. To gain direct exposure to the biotech sector without leverage, you can consider XBI, which tracks the underlying index, or IBB, which tracks the Nasdaq Biotechnology Index. Other inverse leveraged ETFs shown in the table, such as SQQQ, SOXS, SH, PSQ and SPXU, differ in exposure target and multiple because they cover different underlying indexes, including the Nasdaq 100, semiconductors and the S&P 500.
Peer Comparison ETFs| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
 SOXS | Direxion Daily Semiconductor Bear 3X ETF | $41.68 | +4.8% | $3.7B | 1.00% | 28.44% | -93.5% |
 SQQQ | ProShares UltraPro Short QQQ -3x Shares | $37.83 | +4.3% | $1.8B | 0.94% | 8.6% | -40.7% |
 SH | ProShares Short S&P500 -1x Shares | $32.26 | +0.4% | $937.9M | 0.88% | 3.94% | -10.3% |
 PSQ | ProShares Short QQQ -1x Shares | $25.72 | +1.4% | $583.0M | 0.95% | 4.04% | -12.5% |
 SPXU | ProShares UltraPro Short S&P 500 | $34.15 | +1.3% | $417.0M | 0.90% | 6.38% | -30.8% |
Top Holdings| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
 GSEE | Goldman Sachs MarketBeta Emerging Markets Equity ETF | 0.26% | $64.34 | -1.3% | $0.0M | - | 2.21% |
 GTOP | Goldman Sachs Technology Opportunities ETF | 0.15% | $48.61 | -2.0% | $0.0M | - | - |
Direxion Daily S&P Biotech Bear 3X Shares ETF Investor Checkpoints
Here are the points to check before investing in LABD. With inverse leveraged products, it is advisable to understand not only market direction but also the holding period, volatility structure and cost burden before getting involved.
| Checkpoint | What to Confirm | Current Status |
|---|---|---|
| 📉 Direction | Rationale for a biotech downside scenario | Needs confirmation |
| ⏱️ Holding Period | Short-term holding principle due to the daily reset | Mainly short term |
| 🌀 Volatility | Willingness to tolerate magnified gains and losses from leverage | On the high side |
| 💵 Expense Ratio | Cost burden typical of leveraged products | Somewhat high |
Because leverage is combined with a daily reset, in highly volatile markets you can lose money from decay even if you call the direction correctly. It is worth noting that this is a short-term trading product unsuitable for long-term holding.
This product can be used on a limited basis by traders who are targeting a short-term decline in the biotech sector or who need a hedge. We recommend keeping the holding period short and approaching it with full awareness of volatility risk.
SubscribeDisclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of July 2, 2026.
Today's 5 AI picks, all free